These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
992 related articles for article (PubMed ID: 9533543)
1. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543 [TBL] [Abstract][Full Text] [Related]
2. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247 [TBL] [Abstract][Full Text] [Related]
3. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir. Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025 [TBL] [Abstract][Full Text] [Related]
4. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation]. Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912 [TBL] [Abstract][Full Text] [Related]
5. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908 [TBL] [Abstract][Full Text] [Related]
7. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
8. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma. Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes. Guan J; Ma L; Wei L Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195 [TBL] [Abstract][Full Text] [Related]
11. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir. Rivas C; Miller AR; Collado M; Lam EW; Apperley JF; Melo JV Mol Ther; 2001 May; 3(5 Pt 1):642-52. PubMed ID: 11356068 [TBL] [Abstract][Full Text] [Related]
12. Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy. Hasegawa Y; Nishiyama Y; Imaizumi K; Ono N; Kinoshita T; Hatano S; Saito H; Shimokata K Cancer Gene Ther; 2000 Apr; 7(4):557-62. PubMed ID: 10811473 [TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice. Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117 [TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase. Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731 [TBL] [Abstract][Full Text] [Related]
15. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer. Li PX; Ngo D; Brade AM; Klamut HJ Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885 [TBL] [Abstract][Full Text] [Related]
16. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals. Su H; Lu R; Ding R; Kan YW Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975 [TBL] [Abstract][Full Text] [Related]
17. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC. Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034 [TBL] [Abstract][Full Text] [Related]